Skip to content
MarketScale
‹ Back to IndustriesHealthcare

With New Research into Hot Flashes During Menopause, Scientists Expand Treatment Options for Women’s Health

Hot flashes during menopause, a common symptom of women’s natural midlife biology, affect more than 80% of women. The causes behind these common hot flashes have remained a mystery to scientists for years. However, recent research has revealed a breakthrough in understanding the root cause of these uncomfortable, sweaty episodes. Researchers from The Queen’s Medical…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Hot flashes during menopause, a common symptom of women’s natural midlife biology, affect more than 80% of women. The causes behind these common hot flashes have remained a mystery to scientists for years. However, recent research has revealed a breakthrough in understanding the root cause of these uncomfortable, sweaty episodes.

Researchers from The Queen’s Medical Research Institute, the Mayo Clinic’s Center for Translational Science Activities, the Institute for Infectious Diseases and Molecular Medicine at the University of Cape Town, among others, have discovered the root cause of hot flashes is actually non-hormonal. They identified that a particular group of neurons in the brain become activated during menopause, which can cause temperature regulation disturbances leading to hot flashes. The activation of these neurons is due to the decrease of estrogen in the brain’s hypothalamus during menopause.

This discovery is one of many helping scientists better understand the root causes and side effects of menopause. Perhaps the most important consequence of this deeper understanding of hot flashes is that it gives women and their doctors a better framework for understanding the role of hormonal therapy in treating symptoms of menopause.

Much skepticism still surrounds hormone therapy for treating hot flashes during menopause and other menopause symptoms. One 2022 study found links between hormone therapy and increased risks of breast cancer and other health conditions. Other studies showed that the benefits of hormone therapy greatly outweigh the risks. Regardless, the most recent developments around the causes behind hot flashes are providing hope for new, non-hormonal, and perhaps better treatments. One drug, fezolinetant, is a non-hormonal treatment for hot flashes currently under review by the U.S. FDA; the most recent round of clinical trials for the drug found it “reduced the frequency and severity of moderate-to-severe vasomotor symptoms,” otherwise known as hot flashes.

So, can this discovery lead to new non-hormonal targeted therapies for hot flashes during menopause? We sourced perspectives and reactions to this research discovery from menopause and women’s health experts, who seem optimistic about the consequences of these findings.

Barbra’s Thoughts

Barbra Hanna, DO, FACOG, NCMP who is the founder & CEO of MyMenopauseRx has spent the last few years helping women feel well, sleep well and live well with menopause. She is quite excited about the recent discoveries and believes studies like these may lead to non-hormonal treatments to help women lead better lives.

“Estrogens have an important role in every tissue of our body. And hot flashes and night sweats that are debilitating through the menopausal transition really wreak havoc on a woman’s quality of life. Yet, some women can’t or don’t want to use menopausal hormone therapy. The scientific discovery of where those hot flashes and night sweats originate from in our brain is not only fascinating but it’s going to help move science forward to improve the quality of life of so many women.”

Kim’s Thoughts

Can this new research help change society’s attitude and baked-in negative assocations toward menopause? Kim Vopni of Pelvienne Wellness believes it can. Kim is the leading go-to expert for pelvic floor exercise programs that have helped numerous women over the years deal with certain symptoms of menopause. Here are her thoughts on a compendium of reporting out of National Geographic surrounding this and other recent research on menopause.

“I was pleasantly surprised to see an entire section dedicated to vaginal health, specifically genitourinary syndrome of menopause, which is an umbrella term that covers a lot of things that I have been speaking and preaching about for many years and coming up to resistance because the word vagina is considered “inappropriate”, especially in platforms doing to do with social media.

The interesting piece about menopause is actually bringing light. The conversation around menopause is bringing light to pelvic floor disorders. They talked about pelvic floor physical therapy, which in my opinion is the most underused women’s resource that we have. I believe every woman should be seeing one from the time we’re sexually active once a year for the rest of our life, just like we see a dentist once a year for our teeth.

I also like that they did include vaginal, estrogen and the safety surrounding that. I believe and see evidence to support starting it around the time of menopause and staying on it for the rest of our life can help decrease UTIs, can help improve sex, can help with incontinence, all these things that we have thought we need to suffer with.

So, I was really delighted by that particular section. The entire article was well-informed but specific of course to the vaginal piece. I think it was well-informed and I hope that it starts to change the landscape for women going forward.”

Dr. Mindy’s Thoughts

For women in our audience seeking a little advice, how should this new research around menopause help clarify the proper steps and strategies for mitigating menopause’s worst symptoms? Dr. Mindy Pelz, a women’s health and fasting expert, and the founder of Dr. Mindy Pelz Co., reacts to National Geographic’s article and provides perspectives on menopause symptom treatment.

“I wanna highlight a couple of important parts of this article. One, everything the article talks about, the hormonal changes that are happening, are really real for women. The hot flashes, the weight gain, the trouble sleeping. Everything starts to shift after 40, and so your lifestyle needs to shift with those hormones. Things like making sure that you are intermittent fasting and adding in some…cycling in the ketogenic diet and looking at your toxic load. Those all become massively important as you go through the menopausal years.

Now the other thing that this article brings up is that we’re revisiting HRT, and I think this is a great thing. We should look at HRT, we should look at bioidenticals, and look at where the safety is for those specific medications for menopausal women. But we can’t look at medication as the only solution. We’re gonna have to pair a healthy lifestyle to it.

So the article really brought to the surface some important topics that aren’t being discussed culturally. So thank you, National Geographic, but I also wanna highlight that we do need to dive into lifestyle. What are the lifestyle changes and what’s the appropriate medication for you? There is not a one size fits all to these symptoms, and so understanding yourself and what’s gonna working with your doctor to figure out what’s best for you becomes imperative.”

Article written by Galina Mikova.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Health systems are partnering up without changing who owns the hospital

Health systems are partnering up without changing who owns the hospital

Health systems are choosing alliances over mergers, per a July McDermott Will & Schulte analysis and four July deals tracked by Becker's Hospital Review. St. Christopher's, Nemours, Jefferson and Temple signed a nonbinding alliance letter; Palomar UC San Diego Health launched July 1. Ownership stays put; governance, purchasing and outpatient investment absorb the change.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Telemedicine in eye care stops at the retinal scan unless imaging moves home

Telemedicine in eye care stops at the retinal scan unless imaging moves home

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512